Observational Study on the Course of Plasma Glutamine Levels During Critical Illness

NCT02310035 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2015-05-13

No results posted yet for this study

Summary

Blood sampled for standard evaluation will be used for determination of plasma glutamine by Bioprofile Flex Glutamine Sensor at ICU admission

Conditions

  • Glutamine Levels

Sponsors & Collaborators

  • Frisius Medisch Centrum

    lead OTHER

Principal Investigators

  • Matty Koopmans, MSc · Frisius Medisch Centrum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02310035 on ClinicalTrials.gov